Friday, 06 December 2019

BioTech News

  • Aus univ gets massive funding for TB, HPV R&D

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jan, 2013

    Singapore: University of Queensland (UQ) has secured support from the federal government for two research of its projects, aimed at treating papilloma virus and tuberculosis infections. The...Read more

  • Mayo Clinic, Cancer Genetics form OncoSpire JV

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 23 May, 2013

    Singapore: Mayo Clinic and Cancer Genetics have collaborated to form OncoSpire Genomics, a 50:50 joint venture (JV) with the singular goal of improving cancer care by discovering and commer...Read more

  • Japan Minister: Dont be afraid of new science strategy

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

    Singapore: Japanese scientists are skeptical about the country's new strategy for economic growth, which includes an emphasis on applied biomedical research. Several life science organizati...Read more

  • 3SBio to merge with Decade Sunshine

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 11 Feb, 2013

    Singapore: China-based 3SBio entered into an agreement and plan-of-merger with Decade Sunshine, an exempted company with limited liability incorporated under the laws of the Cayman Islands...Read more

  • New Bio Accelerator boosts start-ups in Bangalore, Singapore

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 19 Jul, 2014

    Singapore: In recent years Bangalore has emerged as one of the region's hottest destinations for budding entrepreneurs who have set up more than 5000 companies in the last three years. Esca...Read more

  • R&D expenditure touches $6 bn in Singapore

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 14 Dec, 2012

    Singapore: Singapore's gross expenditure on R&D (GERD) recorded a new high of $6 billion (S$7.4 billion) in 2011, according to the National Survey of R&D, 2011, produced by the Agen...Read more

  • Eisai signs agreement with Epizyme and Roche

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

    Singapore: Eisai has signed an agreement with Epizyme and Roche Molecular Systems to collaborate on the development of a companion diagnostic to help Eisai and Epizyme identify patients fo...Read more

  • VeriStem wins BioSpectrum award for stem cell technology

    BioTech |  Influencers | By BioSpectrum Bureau  | 0 Comment | 15 Mar, 2013

    Development of stem cell therapies requires innovative technologies and processes to overcome safety concerns and VeriStem Technologies of Singapore aims to fulfil this industry need. The c...Read more

  • Starpharma's VP becomes CEO of Viralytics

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 15 Nov, 2012

    Singapore: Starpharma's vice president, Dr Malcolm McColl, has been appointed CEO, Viralytics. Prior to this, Dr McColl was VP, business development, Starpharma, since 2010. He has worked...Read more

  • Bluechiip, Gentris sign cryogenic sample management deal

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 30 Aug, 2012

    Singapore: Bluechiip, which has developed a unique temperature sensing and tracking solution initially for cryogenic sample management in the healthcare and life science industry, signed a...Read more

  • Life Technologies inks supply deal with Novartis

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 01 Aug, 2013

    Singapore: Life Technologies has signed a long-term supply and exclusive licensing agreement with Novartis for immunotherapeutics involving T cells modified to express chimeric antigen rece...Read more

  • Sanofi appoints Dr Gary Nabel as chief scientific officer

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 15 Nov, 2012

    Singapore: Sanofi appointed Dr Gary J Nabel as the senior vice president, chief scientific officer and deputy to the president for Global R&D, effective December 3, 2012. Dr Nabel will...Read more

  • BSI Awards Gallery - Testing

    BioTech |  Analysis | By BioSpectrum Bureau  | 0 Comment | 07 Jan, 2014

    Please visit this space for further updates.....Read more

  • Stanford Univ, DBT India program is a big hit'

    BioTech |  Influencers | By BioSpectrum Bureau  | 0 Comment | 26 Feb, 2013

    Dr Rajiv Doshi, executive director (US), Stanford-India Biodesign (SIB), and consulting assistant professor, Stanford University, US, was one of the many eminent individuals who attended th...Read more

  • Study compares efficacy of oral, injectable polio vaccines

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 17 May, 2013

    Singapore: NanoPass Technologies, a pioneer in intradermal vaccine delivery solutions, is collaborating with the US Center of Disease Control and prevention (CDC) in conducting a large phas...Read more

  • Has collaborative commercialization arrived in India?

    BioTech |  Opinion | By BioSpectrum Bureau  | 0 Comment | 13 Jun, 2013

    Faced with many uncertainties after the introduction of a series of reforms from the 1990s, both Indian and foreign firms have closely followed the growth of the pharmaceutical industry. Lo...Read more

  • A time to rethink talent management

    BioTech |  Opinion | By BioSpectrum Bureau  | 0 Comment | 29 May, 2012

            Year 2011 was an action-packed-year for HR professionals in Asia Pacific life sciences industry. It tested their skills to keep pace with the high level of investment and ...Read more

  • Merck announces Q2 2012 Results

    BioTech |  Company results | By BioSpectrum Bureau  | 0 Comment | 30 Jul, 2012

    Singapore: Merck, known as MSD outside the US and Canada, today announced financial results for the second quarter (Q2) of 2012. While the second quarter non-GAAP EPS increased 11 percent o...Read more



Survey Box

Is APAC region emerging as a leader in assistive technologies?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls